Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. | bioRxiv | 2023 | 37961409 | PubTator, text mining | PubMed |
| Anticancer Effect of E26 Transformation-Specific Homologous Factor through the Induction of Senescence and the Inhibition of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2023 | 37958443 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Biomarkers for Prostate Cancer: From Diagnosis to Treatment. | Diagnostics (Basel) | 2023 | 37958246 | PubTator, text mining | PubMed |
| Expression patterns of claudins in cancer. | Heliyon | 2023 | 37954388 | PubTator, text mining | PubMed |
| Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy. | Ann Med | 2023 | 37939258 | PubTator, text mining | PubMed |
| Resistant cumin cultivar, GC-4 counters Fusarium oxysporum f. sp. cumini infection through up-regulation of steroid biosynthesis, limonene and pinene degradation and butanoate metabolism pathways. | Front Plant Sci | 2023 | 37915505 | PubTator, text mining | PubMed |
| Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling. | Biomed Rep | 2023 | 37901878 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models. | Int J Mol Sci | 2023 | 37894914 | PubTator, text mining | PubMed |
| Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer. | Biomolecules | 2023 | 37892209 | PubTator, text mining | PubMed |
| Thirty Years with ERH: An mRNA Splicing and Mitosis Factor Only or Rather a Novel Genome Integrity Protector? | Cells | 2023 | 37887293 | PubTator, text mining | PubMed |
| NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15. | Precis Clin Med | 2023 | 37885911 | PubTator, text mining | PubMed |
| Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2. | Clin Transl Med | 2023 | 37877351 | PubTator, text mining | PubMed |
| Proteomic characterization of aging-driven changes in the mouse brain by co-expression network analysis. | Sci Rep | 2023 | 37875604 | PubTator, text mining | PubMed |
| Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis. | BMC Cancer | 2023 | 37858101 | PubTator, text mining | PubMed |
| High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma. | Int J Gen Med | 2023 | 37850194 | PubTator, text mining | PubMed |
| Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases. | J Clin Invest | 2023 | 37847564 | PubTator, text mining | PubMed |
| Molecular landscape and functional characterization of centrosome amplification in ovarian cancer. | Nat Commun | 2023 | 37845213 | PubTator, text mining | PubMed |
| Prognostic analyses of genes associated with anoikis in breast cancer. | PeerJ | 2023 | 37842046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=12